News Article 2021

 Home / News / 2021

March 24 2021, David R Brown

HARKE GROUP and Armor Pharma announce new distribution partnership in Austria and Hungary

The HARKE GROUP and Armor Pharma, a leading manufacturer of high-quality pharmaceutical grade lactose, have announced a new the distribution partnership for ARMOR PHARMA's excipients in Austria and Hungary.

The new cooperation with Armor Pharma is a strategic step to support our customers with a full portfolio for oral solid dosage forms and DPI

Thorsten Harke
President of HARKE GROUP

Armor Pharma, part of the Savencia Group, was set-up in 2014 after the completion of a brand-new, purpose-built manufacturing site (EXCIPACT (GMP), ISO 9001 and ISO 22000 certified) for pharma-grade lactose.

Arsim Zhubi, Key Account Manager at ARMOR PHARMA, commented: “Armor Pharma as a pharmaceutical quality lactose grade producer is seeing huge opportunities in many markets for high quality lactose grades for all pharmaceuticals followed with technical assistance, if needed. We value our future distributor HARKE as a competent, responsible and committed partner standing at our side in the field of sales and marketing of pharma quality lactose. ”

Thorsten Harke, President of HARKE GROUP, added: “The new cooperation with Armor Pharma is a strategic step to support our customers with a full portfolio for oral solid dosage forms and DPI. Lactose is highly complementary to our excipients portfolio, thus, allowing us to strengthen our full customer support from idea to implementation.”

Lactose has been used in the pharmaceutical industry for several decades as either diluent in oral solid dosage forms, such as tablets, capsules, sachets (OSDF) or as a carrier for dry powder inhalers (DPI). Several properties such as cost effectiveness, a bland taste, its availability and the compatibility with active ingredients and other excipients have contributed to lactose's popularity as an excipient. Further advantages of lactose are its water solubility, its low hygroscopicity, as well as the excellent physical and chemical stability.

Founded more than 50 years ago, HARKE GROUP is an experienced chemical and pharmaceutical distributor, contract packer, services and solution provider with a strong footprint in Europe and Asia. The Group operates in more than 60 countries worldwide through 16 subsidiaries, serving customers in more than 30 industries supported by formulation expertise from 3 application laboratories. Key markets covered include: Life Sciences, Home & Personal Care, I&I, Coatings, Plastics & Polymers, Plastic Products, Packaging & Services and Imaging. The Group is in the 2nd generation of family ownership.

Source(s): HARKE Group Press Release

Further Information